Chan Henry Lee
General Counsel at BeOne Medicines Ltd. (ONC)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | ONCBeOne Medicines Ltd. | Sell Plan | 1,115 | $375.00 | $418K | -5.5% |
| Aug 13SEC | ONCBeOne Medicines Ltd. | Sell Plan | 2,666 | $360.00 | $960K | -1.5% |
| Aug 3SEC | ONCBeOne Medicines Ltd. | Sell | 1,044 | $323.69 | $338K | +9.5% |
| Jul 24SEC | ONCBeOne Medicines Ltd. | Sell Plan | 1,669 | $325.00 | $542K | +9.1% |
| Jul 10SEC | ONCBeOne Medicines Ltd. | Sell Plan | 664 | $302.46 | $201K | +17.2% |
| Jun 18SEC | ONCBeOne Medicines Ltd. | Sell | 590 | $265.98 | $157K | +33.3% |
| Jun 15SEC | ONCBeOne Medicines Ltd. | Sell | 428 | $257.64 | $110K | +37.6% |
| Jun 10SEC | ONCBeOne Medicines Ltd. | Sell | 711160 held (−82%) | $270.24 | $192K | +31.2% |
| Jun 10SEC | ONCBeOne Medicines Ltd. | Sell | 160 | $271.26 | $43K | +30.7% |
| May 15SEC | ONCBeOne Medicines Ltd. | Sell Plan | 332 | $310.72 | $103K | +14.1% |
| Apr 10SEC | ONCBeOne Medicines Ltd. | Sell Plan | 332 | $311.59 | $103K | +13.8% |
| Mar 13SEC | ONCBeOne Medicines Ltd. | Sell Plan | 341 | $300.00 | $102K | +18.2% |
| Feb 6SEC | ONCBeOne Medicines Ltd. | Sell Plan | 664996 held (−40%) | $348.79 | $232K | +1.6% |
| Feb 6SEC | ONCBeOne Medicines Ltd. | Sell Plan | 996 | $350.00 | $349K | +1.3% |
| Jan 9SEC | ONCBeOne Medicines Ltd. | Sell Plan | 664 | $331.76 | $220K | +6.8% |
| Dec 12SEC | ONCBeOne Medicines Ltd. | Sell Plan | 332 | $318.28 | $106K | +11.4% |
| Dec 12SEC | ONCBeOne Medicines Ltd. | Sell Plan | 332 | $325.00 | $108K | +9.1% |
| Nov 14SEC | ONCBeOne Medicines Ltd. | Sell Plan | 664332 held (−67%) | $348.75 | $232K | +1.6% |
| Nov 14SEC | ONCBeOne Medicines Ltd. | Sell Plan | 332 | $350.00 | $116K | +1.3% |
| Oct 10SEC | ONCBeOne Medicines Ltd. | Sell Plan | 1,112 | $350.00 | $389K | +1.3% |
| Oct 10SEC | ONCBeOne Medicines Ltd. | Sell Plan | 6648,895 held (−7%) | $347.82 | $231K | +1.9% |
| Oct 10SEC | ONCBeOne Medicines Ltd. | Sell Plan | 4,7334,162 held (−53%) | $350.22 | $1.7M | +1.2% |
| Oct 10SEC | ONCBeOne Medicines Ltd. | Sell Plan | 4,162 | $351.12 | $1.5M | +1.0% |
- Sell
General Counsel Chan Henry Lee sold $418K of ONC at $375.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Chan Henry Lee sold $960K of ONC at $360.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Chan Henry Lee sold $542K of ONC at $325.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Chan Henry Lee sold $201K of ONC at $302.46 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Chan Henry Lee sold $192K of ONC at $270.24 — cuts the stake by 82%.
- Sell
General Counsel Chan Henry Lee sold $103K of ONC at $310.72 — pre-scheduled 10b5-1 plan sale.